Gilde Healthcare

@GildeHealthcare

Gilde Healthcare is a Transatlantic growth capital investor focused on private healthcare companies including therapeutics, medical technologies and services.

Netherlands; USA gildehealthcare.com/en Joined February 2014

44 Following 422 Followers 344 Posts

Latest posts 5

Gilde Healthcare @GildeHealthcare Nov 15, 2023

gildehealthcare.com/news/general/g…

gildehealthcare.com Gilde Healthcare closes new Venture&Growth fund at €740 million hard cap - Gilde Healthcare Gilde Healthcare Venture&Growth VI closes at its hard cap with €740 million from a balanced mix of international investors Gilde Healthcare invests in fast growing companies that enable better care...

Gilde Healthcare @GildeHealthcare Oct 17, 2023

gildehealthcare.com/news/general/g…

gildehealthcare.com Gilde Healthcare company SpliceBio enters $216 million Gene Therapy collaboration with Spark... SpliceBio is eligible to receive upfront, opt-in and milestone payments up to $216 million plus royalties Spark secures exclusive worldwide rights to SpliceBio’s proprietary Protein Splicing platform...

Gilde Healthcare @GildeHealthcare Oct 11, 2023

gildehealthcare.com/news/venture-a…

gildehealthcare.com Gilde Healthcare company AM-Pharma announces positive clinical data from Phase 1b study evaluating... AM-Pharma B.V. today announced positive clinical results from the Phase 1b study evaluating the company’s proprietary recombinant alkaline phosphatase, ilofotase alfa, as potential enzyme replacement...

Gilde Healthcare @GildeHealthcare Sep 12, 2023

gildehealthcare.com/news/general/g…

gildehealthcare.com Gilde Healthcare company Moximed reports treatment of first commercial patients post FDA approval -... Moximed, a medical device company on a mission to improve the standard of care for people with knee osteoarthritis (OA), today announced the first commercial cases of the MISHA™ Knee System, an...

Gilde Healthcare @GildeHealthcare Jun 22, 2023

gildehealthcare.com/news/venture-a…

gildehealthcare.com Tagworks Pharmaceuticals announces $64 Million in Series A financing co-led by Gilde Healthcare -... Tagworks Pharmaceuticals BV (“Tagworks”), the Dutch pioneer of Click-to-Release chemistry designed to deliver more effective and safer systemic therapies, today announced a $64 million Series A...